UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000031529
Receipt No. R000036002
Scientific Title Effect of Solubilized medium-chain triacylglycerols on energy metabolism
Date of disclosure of the study information 2018/03/01
Last modified on 2018/03/26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of Solubilized medium-chain triacylglycerols on energy metabolism
Acronym Effect of Solubilized medium-chain triacylglycerols on energy metabolism
Scientific Title Effect of Solubilized medium-chain triacylglycerols on energy metabolism
Scientific Title:Acronym Effect of Solubilized medium-chain triacylglycerols on energy metabolism
Region
Japan

Condition
Condition Healthy adults
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study aims to investigate the effects of the test meal on exercise performance and energy metabolism of healthy adults have regular exercise habits.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Blood sugar level, blood ketone body, lactic acid level, respiratory quotient, the mileage
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 To take a supplement, if necessary with water.
Interventions/Control_2 To take a placebo, if necessary with water.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
39 years-old >=
Gender Male
Key inclusion criteria 1.Japanese male aged 20-39 at the screening visit.
2.Healthy adults.(no serious disease by self-report).
3.Those who do regular exercise habits.
4.Those who are able to sign an informed consent, after fully informed the purpose and contents of the study.
5.Those who are able to come to the hospital on the day of the study.
Key exclusion criteria 1.Those with serious or progressive diseases and symptoms, those with motor function disorders.
2.Currently under medications.
3.Severely damaged exerciser such as bone fracture, tendon rupture, muscle tear in the past year.
4.Those who are stopped to exercise by a doctor.
5.Those who do weight training everyday.
6.Smokers or those who quit smoking for less than 1 year.
7.Those who drink alcohol on the day before the study visit.
8.Those who with an abnormality in the blood test value at the time of screening, except for judged by the Principal doctor as physiological fluctuation range.
9.Those who are participated in other clinical trials within a month before the screening test.
10.Those who with any food or medicine allergies.
11.Those who judged to be inappropriate for participating in the study by Principal Investigator (or other doctor).
Target sample size 4

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yuki Kamioka
Organization NOF CORPORATION
Division name FUNCTIONAL FOODS RESEARCH LABORATORY 3GROUP
Zip code
Address 3-3 CHIDORI-CHO,KAWASAKI-KU,KAWASAKI,KANAGAWA ,JAPAN
TEL 044-281-2502
Email yuki_kamioka@nof.co.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yuki Kamioka
Organization NOF CORPORATION
Division name FUNCTIONAL FOODS RESEARCH LABORATORY 3GROUP
Zip code
Address 3-3 CHIDORI-CHO,KAWASAKI-KU,KAWASAKI,KANAGAWA ,JAPAN
TEL 044-281-2502
Homepage URL
Email yuki_kamioka@nof.co.jp

Sponsor
Institute NOF CORPORATION
Institute
Department

Funding Source
Organization NOF CORPORATION
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 03 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 01 Month 23 Day
Date of IRB
Anticipated trial start date
2018 Year 03 Month 15 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 03 Month 01 Day
Last modified on
2018 Year 03 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036002

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.